comparemela.com

Latest Breaking News On - Equinox science - Page 1 : comparemela.com

EyePoint reports Duravyu trial fail, raising questions

EyePoint reports Duravyu trial fail, raising questions
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Eyepoint duravyuGraig suvannavejhAlimera sciencesBetta pharmaceuticalsEyepoint pharmaceuticalsDiabetic retinopathy severity scaleEquinox scienceChina approved yutiq

EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments

– Positive masked safety data update for EYP-1901 in ongoing PAVIA and DAVIO 2 Phase 2 clinical trials as of October 1, 2023 with no drug related .

United statesAmy phillipsJays dukerChristina tartagliaMarcia sellos mouraJay dukerProgram leadership onBetta pharmaceuticalsAmerican academy of ophthalmologyExchange commissionAmerican society of retina specialistsCompany board of directorsEyepoint pharmaceuticals incEyepoint pharmaceuticalsEyepoint pharmaceuticals nasdaqGreen room communications

EyePoint Pharmaceuticals : EYPT Investor Presentation October 2023 -October 17, 2023 at 05:16 pm EDT

Investor Presentation October 2023 Forward-Looking Statements Various statements made in this presentation.

Exchange commissionBetta pharmaceuticalsForward looking statementsSecurities litigation reform actOcumension therapeuticsEquinox science

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJays dukerAmy phillipsIndiens wirtschaftChristina tartagliaIhre chancenGeorge elstonEyepoint pharmaceuticals nasdaqExchange commissionHarvard business schoolEyepoint pharmaceuticalsGuggenheim securitiesHead of corporate developmentHead of corporate development at enzyvant therapeuticsPiper jaffrayEyepoint pharmaceuticals inc

EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team - EyePoint Pharmaceuticals (NASDAQ:EYPT)

– Stuart Duty appointed to EyePoint's Board of Directors – – George Elston promoted to Executive Vice President – WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc.

United statesChristina tartagliaGeorge elstonJays dukerAmy phillipsEyepoint pharmaceuticals incOccidental collegeGuggenheim securitiesBetta pharmaceuticalsPiper jaffrayJuniper pharmaceuticals incGreen room communicationsCompany compensation committeeExchange commissionHead of corporate developmentPace university

vimarsana © 2020. All Rights Reserved.